Sign In
Buy ENLV
$0.98
-0.0162 (-1.63%)
At Close: Nov 17, 2025
Enlivex Therapeutics Earnings Calls
Sep 30, 2025
(Upcoming)
| Release date | Dec 05, 2025 |
| EPS estimate | -$0.120 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 8.86% |
Jun 30, 2025
-$0.0800 (50.00%)
| Release date | Aug 29, 2025 |
| EPS estimate | -$0.160 |
| EPS actual | -$0.0800 |
| EPS Surprise | 50.00% |
| Revenue estimate | - |
| Revenue actual | - |
Mar 31, 2025
-$0.150 (6.25%)
| Release date | May 30, 2025 |
| EPS estimate | -$0.160 |
| EPS actual | -$0.150 |
| EPS Surprise | 6.25% |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2024
-$0.236 (-47.75%)
| Release date | Feb 26, 2025 |
| EPS estimate | -$0.160 |
| EPS actual | -$0.236 |
| EPS Surprise | -47.75% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Enlivex Therapeutics
Below you can see how ENLV performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 31, 2024
Missed
| Release date | Feb 26, 2025 |
| Price on release | $1.00 |
| EPS estimate | -$0.160 |
| EPS actual | -$0.236 |
| EPS surprise | -47.75% |
| Date | Price |
|---|---|
| Feb 20, 2025 | $1.02 |
| Feb 21, 2025 | $1.00 |
| Feb 24, 2025 | $0.99 |
| Feb 25, 2025 | $0.98 |
| Feb 26, 2025 | $1.00 |
| Feb 27, 2025 | $1.03 |
| Feb 28, 2025 | $1.20 |
| Mar 03, 2025 | $1.02 |
| Mar 04, 2025 | $1.08 |
| 4 days before | -1.96% |
| 4 days after | 8.00% |
| On release day | 3.00% |
| Change in period | 5.88% |
Mar 31, 2025
Beat
| Release date | May 30, 2025 |
| Price on release | $0.94 |
| EPS estimate | -$0.160 |
| EPS actual | -$0.150 |
| EPS surprise | 6.25% |
| Date | Price |
|---|---|
| May 23, 2025 | $0.98 |
| May 27, 2025 | $1.00 |
| May 28, 2025 | $0.95 |
| May 29, 2025 | $0.94 |
| May 30, 2025 | $0.94 |
| Jun 02, 2025 | $0.94 |
| Jun 03, 2025 | $0.94 |
| Jun 04, 2025 | $0.93 |
| Jun 05, 2025 | $0.92 |
| 4 days before | -4.00% |
| 4 days after | -1.71% |
| On release day | 0.427% |
| Change in period | -5.64% |
Jun 30, 2025
Beat
| Release date | Aug 29, 2025 |
| Price on release | $1.05 |
| EPS estimate | -$0.160 |
| EPS actual | -$0.0800 |
| EPS surprise | 50.00% |
| Date | Price |
|---|---|
| Aug 25, 2025 | $1.08 |
| Aug 26, 2025 | $1.08 |
| Aug 27, 2025 | $1.09 |
| Aug 28, 2025 | $1.04 |
| Aug 29, 2025 | $1.05 |
| Sep 02, 2025 | $1.06 |
| Sep 03, 2025 | $1.06 |
| Sep 04, 2025 | $1.07 |
| Sep 05, 2025 | $1.06 |
| 4 days before | -2.78% |
| 4 days after | 0.95% |
| On release day | 0.95% |
| Change in period | -1.85% |
Sep 30, 2025
(Upcoming)
| Release date | Dec 05, 2025 |
| Price on release | - |
| EPS estimate | -$0.120 |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $1.04 |
| Nov 12, 2025 | $1.02 |
| Nov 13, 2025 | $0.99 |
| Nov 14, 2025 | $0.99 |
| Nov 17, 2025 | $0.98 |
Enlivex Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for ENLV?
Enlivex Therapeutics Ltd. (ENLV) has scheduled its earnings report for Dec 05, 2025 before the markets open.
What is the ENLV price-to-earnings (P/E) ratio?
ENLV P/E ratio as of Nov 17, 2025 (TTM) is -1.81.
What is the ENLV EPS forecast?
The forecasted EPS (Earnings Per Share) for Enlivex Therapeutics Ltd. (ENLV) for the first fiscal quarter 2025 is -$0.120.
What are Enlivex Therapeutics Ltd.'s retained earnings?
On its balance sheet, Enlivex Therapeutics Ltd. reported retained earnings of $0 for the latest quarter ending Jun 30, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
